학술논문
Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)
Document Type
Article
Author
Source
In European Journal of Cancer June 2024 204
Subject
Language
ISSN
0959-8049